Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human PDGFD Antibodies:
anti-Rat (Rattus) PDGFD Antibodies:
anti-Mouse (Murine) PDGFD Antibodies:
Go to our pre-filtered search.
Human Polyclonal PDGFD Primary Antibody for IP, WB - ABIN529260
Rizvi, Mertens, Bronk, Hirsova, Dai, Roberts, Kaufmann, Gores: Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis. in The Journal of biological chemistry 2014
Human Polyclonal PDGFD Primary Antibody for IF (p), IHC (p) - ABIN714581
Hurley, Adams, Wang, Jiang, Meo Burt, Du, Xiao: Accelerated Fracture Healing in Transgenic Mice Overexpressing an Anabolic Isoform of Fibroblast Growth Factor 2. in Journal of cellular biochemistry 2015
PDGF-D promotes tumor growth and aggressiveness of colorectal carcinoma. Down-regulation of PDGF-D inactivates Notch1 (show NOTCH1 Antibodies)/Twist1 (show TWIST1 Antibodies) axis, which could reverse epithelial mesenchymal transformation and prevent CRC (show CALR Antibodies) progression.
significant correlations between DNA methylation (show HELLS Antibodies) of the PDGFD gene promoter and the risk of developing either IA or BAVM
This study suggested that epithelial-mesenchymal transition process can be triggered by the PDGF-D/PDGFRb (show PDGFRB Antibodies) axis in tongue squamous cell carcinoma, and then involved in the tumor cell invasion via activation of p38 (show CRK Antibodies)/AKT (show AKT1 Antibodies)/ERK (show EPHB2 Antibodies)/ epithelial-mesenchymal transition pathway.
No specific genotype of rs974819 of Platelet-derived growth factor D demonstrated increased cardiovascular mortality in the total population, however, the male group with genotypes A/A and G/A demonstrated an increased risk that persisted in a multivariate evaluation where adjustments were made for well-known cardiovascular risk factors.
There are four platelet-derived growth factor (PDGF (show PDGFA Antibodies)) genes (PDGFA (show PDGFA Antibodies), PDGFB (show PDGFB Antibodies), PDGFC (show PDGFC Antibodies) and PDGFD) that reside on chromosomes 7, 22, 4 and 11.
polymorphism of rs7950273 in the PDGFD gene is not associated with ischaemic stroke in the Chinese Han population
Novel findings reveal a new paradigm in matriptase (show ST14 Antibodies) activation involving PDGF-D-specific signal transduction leading to extracellular acidosis.
PDGF-D expression is associated with miR (show MLXIP Antibodies)-106a and Twist1 (show TWIST1 Antibodies) in HCC (show FAM126A Antibodies) patients
PDGF-D is highly expressed by ASCs, where it acts as a potent mitogenic factor.
PDGFD, CDH1 and SLIT2 are upregulated in low grade meningiomas and schwannomas compared with healthy tissue.
Inactivation of the Pdgfd gene resulted in a mild phenotype in C57BL/6 mice, and the offspring was viable, fertile and generally in good health.
PDGF-D intensifies fibrogenesis by interfering with the fibrolytic activity of the TIMP-1 (show TIMP1 Antibodies)/MMP-2 (show MMP2 Antibodies)/MMP (show MMP2 Antibodies)-9 (show MMP9 Antibodies) system, and PDGF-D signaling is mediated through both PDGF (show PDGFA Antibodies)-alpha and -beta receptors.
Radial glia require PDGFD-PDGFRbeta signalling in human but not mouse neocortex
PDGF D represents a potentially promising target for prostate carcinoma treatment resistance in the absence of PTEN function, and warrants further laboratory evaluation and clinical study.
Data indicate that the proteolytic processing of full-length PDGF-D is required for PDGF-D activation of preosteoclasts, and that beta-PDGFR (show PDGFRB Antibodies) is present in activated osteoclasts.
identified PDGF (show PDGFA Antibodies)-DD as an important target gene for antiangiogenic therapy due to its pleiotropic effects on vascular and non-vascular cells. PDGF (show PDGFA Antibodies)-DD inhibition may offer new therapeutic options to treat neovascular diseases
Failure of laminin alpha4-mediated down-regulation of PDGF (show PDGFA Antibodies) activity contributes to the progressive renal lesions in this animal model.
These results suggest that PDGF-D induce cellular transformation and promote tumour growth by accelerating the proliferation rate of the tumour cells, and by stimulation of tumour neovascularization.
PDGF-D plays an important role in the pathogenesis of tubulointerstitial injury through binding of PDGF (show PDGFA Antibodies)-Rbeta in obstructive ureteral nephropathy
PDGF (show PDGFA Antibodies)-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns.
The protein encoded by this gene is a member of the platelet-derived growth factor family. The four members of this family are mitogenic factors for cells of mesenchymal origin and are characterized by a core motif of eight cysteines, seven of which are found in this factor. This gene product only forms homodimers and, therefore, does not dimerize with the other three family members. It differs from alpha and beta members of this family in having an unusual N-terminal domain, the CUB domain. Two splice variants have been identified for this gene.
, iris-expressed growth factor
, platelet-derived growth factor D
, spinal cord derived growth factor B
, spinal cord-derived growth factor B
, spinal cord-derived growth factor-B
, platelet-derived growth factor, D polypeptide
, spinal-cord derived growth factor-B protein
, platelet derived growth factor D
, platelet-derived growth factor D-like